Separate and Combined Effects of DNMT and HDAC Inhibitors in Treating Human Multi-Drug Resistant Osteosarcoma HosDXR150 Cell Line

• Enrico Capobianco,

  Affiliations Laboratory of Integrative Systems Medicine (LISM), Institute of Clinical Physiology, CNR, Pisa, Italy, Center for Computational Science (CCS), University of Miami, Miami, Florida, United States of America

  ⨯
• Antonio Mora,

  Affiliations Laboratory of Integrative Systems Medicine (LISM), Institute of Clinical Physiology, CNR, Pisa, Italy, College of Information Technology (CIT), United Arab Emirates University (UAEU), Al Ain, UAE

  ⨯
• Dario La Sala,

  Affiliations Institute of Clinical Physiology, Experimental Oncology Unit, CNR, Siena, Italy, Department of Experimental Biomedicine & Clinical Neuroscience, Policlinico Universitario, Palermo, Italy

  ⨯
• Annalisa Roberti,

  Affiliations Institute of Clinical Physiology, Experimental Oncology Unit, CNR, Siena, Italy, Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Nazar Zaki,

  Affiliation College of Information Technology (CIT), United Arab Emirates University (UAEU), Al Ain, UAE

  ⨯
• Elarbi Badidi,

  Affiliation College of Information Technology (CIT), United Arab Emirates University (UAEU), Al Ain, UAE

  ⨯
• Monia Taranta,

  Affiliation Institute of Clinical Physiology, Experimental Oncology Unit, CNR, Siena, Italy

  ⨯
• Caterina Cinti

  * E-mail: ccinti@ifc.cnr.it

  Affiliation Institute of Clinical Physiology, Experimental Oncology Unit, CNR, Siena, Italy

  ⨯